baber/WOPTO huggingface dataset:
Patent CA-2839793-A1 (CA)
Title: Sensor with mn2o3 catalyst and process for manufacturing the same
Inventor: KOELKER KARL-HEINZ
IPC: G01N27/416
Filed: 2014-01-17
Abstract: A process for detecting an analyte in a sample is described, comprising the steps of: S1.       providing a sensor, (2) the sensor comprising: a.    a conductive material (22); b.    a first electrode material (24) superimposing at least a part of the conduc-tive material (22) to form a working electrode (6), wherein the first electrode material (24) is adapted to perform at least one de-tection reaction when the analyte is present in the sample, wherein the first electrode material comprises Mn2O3 particles; S2.       applying a voltage to the working electrode (6); wherein the voltage is selected from the voltage range at which H2O2 in the sample will be reduced at the working electrode (6). Further, a sensor (2) for detecting an analyte in a sample (26) is disclosed.  The sensor comprises: i. a substrate (4), wherein the substrate (4) comprises a sensor surface (20), ii.    a conductive material (22) superimposing at least a part of the sensor surface (20), iii. a first electrode material (24) superimposing at least a part of the conductive mate-rial (22) to form a working electrode (6), wherein the first electrode material (24) is adapted to perform at least one detection reaction when the analyte is present in the sample (26), wherein the first electrode material (24) compris-es Mn/O3 particles. Also, a sensor system with a sensor as mentioned before is disclosed together with a detector device.
Patent CA-2840336-A1 (CA)
Inventor: IMAI TOSHIYASU
IPC: A61P25/04
Filed: 2012-05-25
Abstract: A P2X4 receptor antagonist such as paroxetine and a diazepinedione derivative represented by general formula (IX) is used as a prophylactic or therapeutic agent for neuropathic pain associated with Guillain-Barre syndrome. (In the formula, R1 represents a hydrogen atom, an alkyl group having 1-8 carbon atoms, or the like; R2 and R3 independently represent a hydrogen atom, an alkyl group having 1-8 carbon atoms, or the like; R4 and R5 independently represent a hydrogen atom, or the like; and W represents a 5- or 6-membered heterocyclic ring which contains 1-4 nitrogen atoms as ring-constituting elements and which may have a substituent.)
Patent CA-2841722-A1 (CA)
Inventor: AVIDOV AMIT
IPC: A23L25/00
Filed: 2012-07-17
Abstract: A maize plant or plant part having a partially or fully multiplied genome is provided. Also provided are methods of generating and using the plant or parts thereof, and products comprising same.
Patent CA-2845674-A1 (CA)
Inventor: ZERVOS CLARK
IPC: G01N33/564
Filed: 2012-11-22
Abstract: Described herein is a method for identifying atypical antibodies in blood or blood product manufacturing processes that may produce false positives in quality control testing on intermediate or final products.
Patent CA-2846149-A1 (CA)
Inventor: REITBLAT ABRAM
IPC: A61B17/34
Filed: 2014-03-12
Abstract: A system for percutaneous spinal fusion may include two spaced apart blades connected together by a coupling such that the blades define a percutaneous pathway from a skin incision to an implanted pedicle fastener. The coupling may be c-shaped and may have at least one flexible tab for engaging one or more holes along the length of the blades. If one of the blades becomes disconnected from the pedicle fastener, a supplemental access device may be provided comprising a tubular body having a channel therein for receiving the other of the blades. If both of the blades become disconnected, a supplemental access device may be provided comprising a gripping member received within a locking member. The gripping member may have two legs engageable with the pedicle fastener, and the locking member may move along the gripping member to prevent the legs from disengaging the pedicle fastener.
Patent CA-2846578-A1 (CA)
Inventor: BLANCHARD FREDERICK W
IPC: B60P3/22
Filed: 2014-03-14
Abstract: A valve assembly for mounting a pump to a storage tank of a vehicle includes an upper flange, a lower flange, and a wall extending axially between the upper flange and the lower flange, the lower flange being offset by the wall relative to the upper flange to facilitate installation of the pump on the vehicle.
Patent CA-2847403-A1 (CA)
Title: System, method and computer program for enabling signings and dedications on a remote basis
Inventor: POPOVIC MILOS
IPC: G06Q50/10
Filed: 2004-11-25
Abstract: A system, method and computer program for enabling signings/dedications on a remote basis is provided. A first computer at a first location is associated with an individual from whom a signature or dedication is required. A second computer at a location where the signing or dedication is required is linked to the first computer so as to provide a two-way audiovisual communication system. The second computer is operable to receive input from one or more individuals regarding their request for a signature and/or dedication, and to communicate the request to the first computer.  The first computer is operable to permit the individual associated with the first computer to review the request, and based on such request provide a signature and/or personalized dedication as an input to an input device connected to the first computer. The first computer transmits the signature and/or personalized dedication from the first computer to the second computer. The second computer is operable to receiving the signature and/or personalized dedication, and provide the signature and/or personalized dedication to a plotter device connected to the second computer.  The plotter device is operable to apply the signature and/or personalized dedication introduced to the plotter device to an article, substantially in the handwriting of the individual associated with the first computer, based on the operation of the plotter device. A computer program for enabling the functions described is also provided. A  related method is also disclosed.
Patent CA-2852989-A1 (CA)
Title: Compositions for treating bone diseases and broken bones
Inventor: GENBERG CARL
IPC: A61K31/575
Filed: 2012-09-13
Abstract: Disclosed herein are methods of promoting osteogenesis in a subject, comprising administering a composition comprising a therapeutically effective amount of at least one cationic steroid antimicrobial (CSA). Also disclosed herein are methods of promoting osteogenesis in a subject in need of such promotion, comprising administering a composition comprising a therapeutically effective amount of at least one CSA. Additionally, disclosed herein are compounds and compositions comprising at least one CSA, or a pharmaceutically acceptable salt thereof, for use in the treatment of bone disease or the treatment of broken bones. Kits comprising such compositions and instructions on such methods are also contemplated herein.
Patent CA-2854266-A1 (CA)
Title: 3,7-disubstituted octahydro-2h-pyrido[4,3-e][1,3]oxazin-2-one antibiotics
Inventor: HUBSCHWERLEN CHRISTIAN
IPC: C07D498/04
Filed: 2012-11-29
Abstract: The invention relates to antibacterial compounds of Formula (I) wherein G and K are as defined in the description; and salts of such compounds.
Patent CA-2855151-A1 (CA)
Inventor: FAVERO RICHARD FRANCIS
IPC: H04L9/00
Filed: 2012-11-12
Abstract: A method for transmitting an encrypted message from a messaging server (106) to a handset (104) comprising the steps of receiving, at the messaging server (106) and from a sender computer (102), a message to be sent to the handset (104) and a handset identifier associated with the handset and determining that the handset is not registered with the messaging server (106) by determining that the handset identifier does not have an associated handset encryption key stored at the messaging server. The handset (104) is registered by sending a notification to the handset requesting registration, receiving back a handset encryption key associated with the handset identifier; and storing the handset encryption key against the handset identifier at the messaging server which is to be used to encrypt the received message before sending. Prior to registering the handset (104), intermediate encryption of the message may be employed to create an intermediate encrypted message to be stored at the messaging server.
Patent CA-2857101-A1 (CA)
Inventor: TERHOLSEN STEFAN
IPC: B04B7/08
Filed: 2012-12-10
Abstract: The invention relates to a fully jacketed screw centrifuge, comprising a rotatable drum (3) having an in particular horizontally oriented rotational axis, a rotatable screw (5) arranged in the drum (3), at least one discharge opening (19) oriented at an angle to the rotational axis of the fully jacketed screw centrifuge for discharging solid from the drum (3) in the jacket of the drum (3), wherein a collecting chamber (25) for solid, which surrounds the drum (3) that rotates during operation in some sections and which does not rotate during operation, is associated with the at least one discharge opening (19), wherein at least one hose segment (29) not circumferentially closed in the cross-section is arranged in the collecting chamber (25).
Patent CA-2857474-A1 (CA)
Title: Medicine bottle
Inventor: OSCHWALD HANS
IPC: A61J1/20
Filed: 2014-07-23
Abstract: A medicine bottle with a bottle body having an inner space to receive a medicine, and a bottle top which is attached to the bottle body is provided. The bottle top has a riser tube which projects into the inner space to facilitate a pumping of the medicine out of the inter space through the riser tube and out of the medicine bottle. The inner space is delimited by a bottom side, of which the height varies over a base area of the bottle body, between a maximum height and a minimum height, to allow the medicine to accumulate in the region of the minimum height in the case of a low fill level of medicine, and a length of the riser tube is chosen such that the riser tube projects into the inner space than to the maximum height of the bottom side.
Patent CA-2858754-A1 (CA)
Inventor: GILLIA OLIVER
IPC: C01B3/00
Filed: 2012-12-10
Abstract: A tank intended for the storage of hydrogen by absorption into material, including a first part (I) and a second part (II), each of the first (I) and second (II) parts including a barrel (4), closed at one first longitudinal end (4.1) by a substantially hemispherical part (6), the two parts (I, II) being joined by the second open longitudinal end (4.2) of the barrel (4) by means of an assembly plate (2), the above-mentioned tank including two heat exchangers (12), each being contained in one of the two parts (I, II) and intended to be under the same hydrogen pressure, the above- mentioned tank also having means of supply and evacuation of heat transfer medium circulating in the above-mentioned heat exchangers integrated in the assembly plate, and means of supply and collection of hydrogen.
Patent CA-2858916-A1 (CA)
Title: Method and measuring system for ascertaining density of a fluid
Inventor: VAN DIJK COEN
IPC: G01N9/00
Filed: 2012-11-22
Abstract: In the method of the invention, respectively the measuring system of the invention, a fluid contacted, vibratory body (10) is provided, which is caused to vibrate in such a manner that it at least partially executes mechanical oscillations with a resonant frequency (resonant oscillations) dependent on the density of the fluid contacting a first surface (10+) of the vibratory body, as well as also dependent on the temperature of the vibratory body. For producing at least one oscillation measurement signal, which has at least one signal component with a signal frequency corresponding to the resonant frequency and consequently dependent on the density of the fluid, vibrations of the vibratory body are registered by means of an oscillation sensor (51). Moreover, a temperature sensor (61) is applied thermally attached with a non fluid contacting, second surface (10#) of the vibratory body for producing a temperature measurement signal representing a time curve of a variable temperature of the vibratory body. As a function also of a thermal conductivity and a heat capacity of the vibratory body, the temperature measurement signal can follow, however time delayed, a change of the temperature of the vibratory body from a beginning temperature value, .THETA.10,t1, to a new temperature value, .THETA.10,t2. Based on the oscillation measurement signal as well as the temperature measurement signal, density, measured values are produced representing the density, wherein, during such, discrepancies possibly occurring between the time curve of the temperature of the vibratory body and the temperature measurement signal are taken into consideration, respectively at least partially compensated.
Patent CA-2859986-A1 (CA)
Inventor: STEWART SUSAN
IPC: A61K31/58
Filed: 2012-12-21
Abstract: The present invention provides methods and compositions for treating cancers using a combination of a CYP 1 7 inhibitor and an additional therapeutic agent which modulates the PBK/ Akt/mTOR pathway. In one aspect, the invention provides methods for the treatment of a disorder in a human subject. In some embodiments, the disorder is a neoplastic disorder. In some embodiments, the neoplastic disorder is a cancer. In some embodiments, the method comprises administering to said subject a 17a-hydroxylase/C17,20-lyase inhibitor (CYP17 inhibitor) and an additional agent, wherein the additional agent is a PBK inhibitor and/or mTOR inhibitor.
Patent CA-2860642-A1 (CA)
Inventor: NELSON JEFFREY L
IPC: A61K31/197
Filed: 2013-01-10
Abstract: Disclosed is the combination of beta-hydroxy-beta-methylbutryate, arginine, and glutamine for use in a method of treating a diabetic ulcer in a diabetic individual having at least one of: (a) a serum albumin level of less than or equal to 4.0 g/dL, and/or (b) an Ankle-Brachial Index of less than 1Ø 9. Also disclosed is the use of the combination of beta-hydroxy-beta-methylbutryate, arginine, and glutamine for the manufacture of a medicament for use in the treatment of a diabetic ulcer in a diabetic individual having at least one of: (a) a serum albumin level of less than or equal to 4.0 g/dL, and/or (b) an Ankle-Brachial Index of less than 1Ø In certain embodiments, the combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine are orally administered via a nutritional composition.
Patent CA-2864533-A1 (CA)
Inventor: BETTI GIUSEPPE
IPC: F28F3/12
Filed: 2014-09-25
Abstract: Large surface heat exchanger element composed of two metal plates provided with half spheroidal cavities, Juxtaposed and united as to conform a sealed space in such away that the so conformed space provides resistence to internal or external pressure similar to a set of interconnected spherical wessels.
Patent CA-2866205-A1 (CA)
Inventor: HILLAN JOHN
IPC: H04W28/22
Filed: 2013-04-08
Abstract: Aspects disclosed herein relate to enabling specification of different bit rates in each direction for NFC peer communications. In one example, a target NFC device may be configured to receive a parameter selection request including a first bit rate value to be used for transmissions from an initiator NFC device to the target NFC device and a second bit rate value to be used in the other direction, and to function in either a first or a second target sub-state based on the first bit rate value. In another example, an initiator NFC device may be configured to determine a first bit rate value to be used for transmissions from an initiator NFC device to a target NFC device and a second bit rate value to be used in the other direction, and to transmit the first and second bit rate values in a parameter selection request message.
Patent CA-2866416-A1 (CA)
Title: Liquid or particulate tank mix adjuvant comprising a base selected from a mixture of carbonate and hydrogencarbonate
Inventor: SCHNABEL GERHARD
IPC: A01N25/02
Filed: 2013-03-19
Abstract: The present invention relates to q method for preparing a tank mix, which comprises the step of contacting a pesticide formulation, water, and a tank mix adjuvant, wherein the tank mix adjuvant comprises a base, which contains a mixture of an alkali salt of carbonate and an alkali salt of hydrogencarbonate, and wherein the tank mix adjuvant is present in form of an aqueous liquid, which contains at least 50 g/l of the base, or in form of a particulate solid, which contains at least 10 wt% of the base. The invention also relates to a use of a tank mix adjuvant for increasing the efficacy of a pesticide, wherein the tank mix adjuvant comprises a base, which contains a mixture of an alkali salt of carbonate and an alkali salt of hydrogencarbonate, and wherein the tank mix adjuvant is present in form of an aqueous liquid, which contains at least 50 g/l of the base, or in form of a particulate solid, which contains at least 10 wt% of the base; to a tank mix adjuvant which comprises an auxiliary and a base, which contains a mixture of an alkali salt of carbonate and an alkali salt of hydrogencarbonate, wherein the tank mix adjuvant is present in form of an aqueous liquid, which contains at least 50 g/l of the base; to a tank mix adjuvant which comprises an auxiliary and a base, which contains a mixture of an alkali salt of carbonate and an alkali salt of hydrogencarbonate, wherein the tank mix adjuvant is present in form in form of a particulate solid, which contains at least 10 wt% of the base; and to a method of controlling phytopathogenic fungi and/or undesired vegetation and/or undesired insect or mite attack and/or for regulating the growth of plants, wherein the tank mix is allowed to act on the respective pests, their environment or the plants to be protected from the respective pest, on the soil and/or on undesired plants and/or the crop plants and/or their environment.
Patent CA-2867178-A1 (CA)
Inventor: RIEGEL CHRISTOPHER K
IPC: G09F9/00
Filed: 2012-03-02
Abstract: A digital display system includes a transparent outer protective panel, a transparent inner protective panel, and a translucent digital video display located between the outer and inner protective panels. An integrated media player is operably connected to the translucent digital video display so that full-motion videos displayed on the translucent digital video display are viewed through the outer protective panel and items can be viewed through the translucent digital video display. The digital display system can be incorporated into any environment where a product is located behind a glass enclosure such as freezers, coolers, security glass, jewelry cases, liquor cases, cosmetic cases, and the like. In retail environments, the digital display systems can also be incorporated into entry doors, windows, drive-thru windows, teller windows, and any other location where there is traditionally glass and you want to focus consumer attention obstructing the customer's line of site.
Patent CA-2867540-A1 (CA)
Inventor: HYNDMAN ALEXANDER WILLIAM
IPC: C02F1/54
Filed: 2004-01-08
Abstract: Techniques for the treatment of oil sand tailings that may result from a paraffinic froth treatment operation may include thickening the oil sand tailings in a thickener vessel including outlets for withdrawing underflow and overflow components and a device, such as a sparge apparatus, for providing gas bubbles into the thickening vessel.
Patent CA-2867621-A1 (CA)
Title: Fast diagnosis and personalized treatments for acne
Inventor: LI HUIYING
IPC: C12Q1/68
Filed: 2013-03-15
Abstract: Methods of diagnosing and treating patients afflicted with acne, including diagnosing one as having acne if the individual possesses RT4, RT5, RT7, RT8, RT9, or RT10. Methods for treating acne include administering an effective amount of a drug specifically targeting RT4, RT5, RT7, RT8, RT9, or RT10, such as small molecules, antisense molecules, siRNAs, biologics, antibodies, phages, vaccines, or combination thereof.
Patent CA-2872083-A1 (CA)
Title: Pharmaceutical composition
Inventor: JOHANSEN THUE
IPC: A61K38/28
Filed: 2013-05-01
Abstract: A combination comprising at least a first insulin-like compound and a second insulin-like compound for treating a condition or a diseasein a subject in need thereof where administration of insulin would be of benefit to said subject is described. The combination is administered in an amount to achieve a beneficial glycaemic control in said subject as determined by the levels of HbA1c in said subject after administration of said combination at the largest meal of the day for said subject; wherein said beneficial glycaemic control by said combination is superior to any glycaemic control achieved by an equivalent dose of IGlar in said subject as determined by the levels of HbA1c in said subject after administration of IGlar for said subject and/or wherein said beneficial glycaemic control by said combination comprises decreasing the levels of HbA1c in said subject to about 7 or less after administration of said combination at the largest meal of the day; wherein said first insulin- like compound is longer acting than the second insulin-like compound; wherein said combination is administered at the largest meal of the day for said subject; wherein said first insulin-like compound is at least a long acting insulin, preferably an ultra long acting insulin; wherein said first insulin-like compound is a derivative of a naturally occurring insulin or is an insulin analogue; and wherein said first insulin-like compound has a side chain attached to the a-amino group of the N-terminal amino acid residue of the B chain or to the e-amino group of a Lys residue present in the B chain of the parent insulin, the side chain being of the general formula (I):- W-X-Y-Z.
Patent CA-2876558-A1 (CA)
Title: Biological method for producing cis-5-hydroxy-l-pipecolic acid
Inventor: FUJII TADASHI
IPC: C12N9/02
Filed: 2013-06-12
Abstract: The present invention provides a method for producing cis-5-hydroxy-L-pipecolinic acid. In the production method according to the present invention, a genetically modified microorganism that is so modified as to produce cis-5-hydroxy-L-pipecolinic acid directly can be used. The present invention also provides the genetically modified microorganism. A preferred embodiment of the present invention is characterized in that a genetically modified microorganism having both DNA encoding a protein involved in the biosynthesis of L-pipecolinic acid and DNA encoding a protein having a hydroxylase activity for cis-position-5 in L-pipecolinic acid is cultured in a culture medium and cis-5-hydroxy-L-pipecolinic acid is collected from a culture solution.
Patent CA-2878577-A1 (CA)
Inventor: LADTKOW CASEY M
IPC: A61B1/267
Filed: 2013-07-26
Abstract: A microwave ablation system configured for use in luminal network is provided. The microwave ablation system includes a microwave energy source and a tool for treating tissue. An extended working channel is configured to provide passage for the tool. A locatable guide, translatable through the extended working channel, is configured to navigate the extended working channel adjacent a target.
Patent CA-2881249-A1 (CA)
Inventor: BURGER THOMAS
IPC: F24S10/40
Filed: 2015-02-06
Abstract: The object of the invention is a solar collector tube (2) for heating up gases, which comprises two tubes (21, 22) for forming a tube wall, disposed in a spaced-apart relationship so as to form an intermediate space, wherein the outer tube (21) is made of glass, a translucent synthetic material or composite material and the inner tube (22) is made of metal or a synthetic or composite material, wherein the solar collector tube (2) is open at both ends, at least in the region of the inner tube (22), for allowing passage of the gas to be heated.